MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jdiacomp.2023.108411

Медицинская библиотека · Journal of diabetes and its complications · 2023

Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice.

Desai Nihar R, Navaneethan Sankar D, Nicholas Susanne B, Pantalone Kevin M, Wanner Christoph, Hamacher Stefanie, Gay Alain, Wheeler David C

Наблюдательное исследованиеМногоцентровое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

AIMS: Contemporary patterns of care of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and the adoption of finerenone are not known. The FINE-REAL study (NCT05348733) is a prospective observational study in patients with CKD and T2D to provide insights into the use of the nonsteroidal mineralocorticoid receptor antagonist (MRA) finerenone in clinical practice.

METHODS

FINE-REAL is an international, prospective, multicenter, single-arm study enrolling approximately 5500 adults with CKD and T2D in an estimated 200 sites across 22 countries. The study is anticipated to be ongoing until 2027.

RESULTS

The primary objective is to describe treatment patterns in patients with CKD and T2D treated with finerenone in routine clinical practice. Secondary objectives include assessment of safety with finerenone. Other endpoints include characterization of healthcare resource utilization and occurrence of newly diagnosed diabetic retinopathy or its progression from baseline in patients with existing disease. A biobank is being organized for future explorative analyses with inclusion of participants from the United States.

CONCLUSIONS

FINE-REAL is the first prospective observational study with a nonsteroidal MRA in a population with CKD and T2D and is expected to provide meaningful insights into the treatment of CKD associated with T2D. FINE-REAL will inform decision-making with respect to initiation of finerenone in patients with CKD and T2D.

Для цитирования: Desai Nihar R, Navaneethan Sankar D, Nicholas Susanne B, Pantalone Kevin M, Wanner Christoph, Hamacher Stefanie, Gay Alain, Wheeler David C. Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice.. Journal of diabetes and its complications. 2023. DOI: 10.1016/j.jdiacomp.2023.108411.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.